Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Magle Chemoswed | MAGLE | 15. mai 2024 | 32.40 | 0.00 |
Medivir | MVIR | 15. mai 2024 | 2.92 | +0.34 |
Mendus AB | IMMU | 15. mai 2024 | 0.45 | -4.89 |
Miris Holding | MIR | 15. mai 2024 | 0.16 | -4.32 |
Moberg Pharma | MOB | 15. mai 2024 | 26.42 | -5.78 |
Modus Therapeutics | MODTX | 15. mai 2024 | 1.01 | -1.46 |
Nanexa | NANEXA | 15. mai 2024 | 0.92 | +9.03 |
Nanologica | NICA | 15. mai 2024 | 6.08 | +2.70 |
NextCell Pharma AB | NXTCL | 15. mai 2024 | 1.20 | -1.23 |
Nykode Therapeutics | NYKDO | 15. mai 2024 | 13.05 | 0.00 |
ODI Pharma | ODI | 15. mai 2024 | 7.60 | -1.30 |
Oncopeptides | ONCO | 15. mai 2024 | 2.88 | -12.08 |
OncoZenge | ONCOZ | 15. mai 2024 | 3.79 | -0.39 |
OptiCept Technologies | OPTI | 15. mai 2024 | 2.17 | +0.93 |
Orexo | ORX | 15. mai 2024 | 19.80 | +1.54 |
OssDsign | OSSD | 15. mai 2024 | 9.50 | -1.45 |
Peptonic Medical | PMED | 15. mai 2024 | 0.01 | +6.45 |
PharmaLundensis | PHAL | 15. mai 2024 | 0.57 | 0.00 |
Pila Pharma | PILA | 15. mai 2024 | 2.44 | 0.00 |
Polymer Factory Sweden | POLYMER | 15. mai 2024 | 0.69 | -4.79 |
Probi | PROB | 15. mai 2024 | 210.00 | -1.87 |
Promimic AB | PRO | 15. mai 2024 | 26.30 | -0.75 |
QuiaPEG Pharmaceuticals Holding AB | QUIA | 15. mai 2024 | 0.07 | +6.56 |
RaySearch Laboratories B | RAYB | 15. mai 2024 | 123.40 | -6.52 |
Redwood Pharma | REDW | 15. mai 2024 | 1.05 | -7.46 |
Respiratorius | RESP | 15. mai 2024 | 0.24 | -3.60 |
Saniona | SANION | 15. mai 2024 | 1.80 | -0.55 |
Scandinavian ChemoTech B | CMOTECB | 15. mai 2024 | 2.30 | -1.71 |
Scandion Oncology | SCOL | 15. mai 2024 | 1.35 | -3.57 |
Spago Nanomedical | SPAGO | 15. mai 2024 | 0.26 | -5.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.